CHF50.20
0.20%
SIX Swiss Exchange, Oct 28, 05:30 pm CET. Closed.
ISIN
CH0038389992
Symbol
BION

BB Biotech Target price 2026 - Analyst rating & recommendation

BB Biotech Classifications & Recommendation

Buy
89%
Hold
11%

BB Biotech Price Target

Target Price CHF72.36
Price CHF50.20
Potential
Number of Estimates 4
4 Analysts have issued a price target BB Biotech 2027 . The average BB Biotech target price is CHF72.36. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 9 analysts: 8 Analysts recommend BB Biotech to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the BB Biotech stock has an average upside potential 2027 of . Most analysts recommend the BB Biotech stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Million CHF ??? ???
??? ???
Net Margin ??? ???
??? ???

4 Analysts have issued a sales forecast BB Biotech 2026 . The average BB Biotech sales estimate is

. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .

This results in the following potential growth metrics:

Revenue Estimates

2025 CHF617m 449.48%
2026
2027
2028

5 BB Biotech Analysts have issued a net profit forecast 2026. The average BB Biotech net profit estimate is

. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 CHF578m 661.70%
2026
2027
2028

Net Margin

2025 93.74% 38.62%
2026
2027
2028

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share CHF ??? ???
??? ???
P/E ???
EV/Sales ???

5 Analysts have issued a BB Biotech forecast for earnings per share. The average BB Biotech EPS is

. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 CHF10.54 663.77%
2026
2027
2028

P/E ratio

Current 2.58 151.84%
2026
2027
2028

Based on analysts' sales estimates for 2026, the BB Biotech stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current -1.09
2026
2027
2028

P/S ratio

Current
2026
2027
2028

Current BB Biotech Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
Analyst Rating Date
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today